{
  "pmid": "41434194",
  "title": "Alzheimer's Imaging Consortium.",
  "abstract": "Hippocampal hyperactivation in fMRI has been observed in individuals at risk for Alzheimer's Disease (AD), both those with normal cognition (NC) and those with mild cognitive impairment (MCI). This hyperactivity may serve as a biomarker for identifying at-risk individuals, as well as a promoter of tau pathology, thus offering the potential to delay or avert cognitive decline through early interventions. Multimodal neuroimaging approaches are essential to better understand hippocampal hyperactivity. fMRI provides indirect hemodynamic measures of neural activity with high spatial resolution, whereas magnetoencephalography (MEG) is a more direct indicator with high temporal resolution. We compared fMRI and MEG responses in older individuals, with no risk factors for AD, to examine the relationship between these measures of hippocampal episodic memory engagement and provide insights into hyperactivity mechanisms to inform future interventions. 21 participants (xÌ„ Significant activation contrasts were identified for fMRI and MEG beta band activity (Figs 1 & 2). There was a significant, positive relationship between fMRI and MEG metrics of hippocampal engagement (R The importance of these results is multifaceted. First, we defined a direct neural read-out of hippocampal activity in MEG that can index memory processes known to be affected in AD pathology. Second, we demonstrated the relationship between two complementary measures of hippocampal engagement (fMRI pattern separation, MEG repetition suppression) and their association to lure discrimination performance. Third, we established a normative distribution of both putative biomarkers that can be used for participant selection in future intervention trials.",
  "disease": "alzheimer disease"
}